Replies to post #100428 on NanoViricides Inc. (NNVC)

[robi-1-kenobi]

What prop for share price? Ebola testing with USAMRIID as stated in the recent 10K finding (in red below). Good results will rocket the SP with expectations of grants and more, bad results will tank the SP:

From Page 5 of 10K:

In September 2014, we announced that we have already completed design of novel anti-Ebola drug candidates, based on “in silico” or molecular modeling approach, and synthesis has also begun. We believe that we will be able to work with our previous collaborators at the USAMRIID, and also at the NIH, to begin testing the potential utility of these drug candidates in cell cultures and animal models soon.

From Page 47 of 10K:

In July 2010, our collaborators at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) presented the data on evaluation of anti-Ebola/Marburg nanoviricides. Significant efficacy was reported to have been achieved in cell culture studies. Animal studies indicated improvement in lifetime in the uniformly lethal mouse model. Further improvement in chemistry and dosage levels may be expected to lead to significant survival.

From Page 51 of 10K:

To date, we have entered into the following collaborations.

Cooperative Research and Development Agreement for Material Transfer, dated October 15, 2007, between NanoViricides, Inc. and United States Army Medical Research Institute of Infectious Disease (“Laboratory”).

The term of the agreement was for one year initially and extended for an additional year. It has been extended again, based on positive results. The Company shall invent, develop, and provide to the laboratory, Nanoviricides® that are expected to be capable of attacking a multiplicity of different Ebola and Marburg viruses. The Laboratory shall assess in vitro and in vivo activity of the anti-Ebola Nanoviricides® provided against the virus.

There is no payment by the Company to the Laboratory, nor from the Laboratory to the Company. USAMRIID has federal funding to support their part of the work.

[drkazmd65]

There's nothing to hold this dog up until about 2018.

Other than overlooking the fact that it is only likely a few months until we find out whether, or not, Ebolacide2 is effective in laboratory animals,....

And the fact that the Shelton Facility is likely to go online sometime in early 2015,...

And the fact that TOX testing will still likely be started well before deep into 2015,...

And the fact that Phase I and Phase II testing will also be happening long before that 2018 date suggested,...

Yes - you are "absolutely" correct that there is nothing to 'hold this dog up' before then.

I think it'll trend lower and lower over time. Of course then they'll just kick the can further down the road as usual

.

And I think that each of the milestones I list above will push the trendline incrementally higher and higher over time as they acheive these milestones one at a time.

Which of these ideas will end up closer to the truth?

I like our odds.